Jpmorgan Chase & Co »

TherapeuticsMD shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of TherapeuticsMD (TXMD) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in TherapeuticsMD

Tip: Access up to 7 years of quarterly data

All positions including TherapeuticsMD held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in TherapeuticsMD by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $659 293 2.25
2023-09-30 $944 313 3.02
2023-06-30 $1.3k 313 4.12
2023-03-31 $1.4k 363 3.85
2022-12-31 $1.8k 476 3.85
2022-06-30 $3.6k 336 10.60